CellGenTech, Inc. announced a private placement of 6,700 common shares at a price of ¥120,000 for gross proceeds of ¥804,000,000 on May 18, 2018. The company will also issue 6,600 warrants. The warrant is exercisable into 10,232 shares at a fixed exercise price of ¥120,000 from June 1, 2018 to December 31, 2019. The transaction will include participation from existing investor Nissui Pharmaceutical Co., Ltd. for 2,917 shares and other investor. The investors will acquire 30.385% stake in the transaction, pursuant to the closing of the transaction. The transaction will take place through third party allotment. The transaction was approved by the board of directors of the investor. The transaction is expected to close on May 30, 2018.